Long-Term Progression-Free and Overall Survival in Two Melanoma Patients Treated with Patient-Specific Therapeutic Vaccine Eltrapuldencel-T After Resection of a Solitary Liver Metastasis.
Hepatic metastases from melanoma are usually associated with recurrence and short survival, even in patients with a solitary metastasis. Two patients, one with melanoma of unknown primary and one with ocular melanoma, underwent resection of a solitary liver metastasis followed by treatment with eltrapuldencel-T, a patient-specific therapeutic vaccine consisting of autologous dendritic cells loaded with antigens from irradiated melanoma cells obtained from an autologous tumor cell line. Following surgical resection, the ocular melanoma patient remained progression free for more than 4.5 years and was known to be alive more than 8.5 years later, while the other patient, who previously had experienced lung and small bowel metastases, has remained disease free and is alive more than 12 years later. These two cases illustrate how immunotherapies designed to induce immune responses to tumor-associated antigens (TAA), as opposed to releasing previously existing responses to TAA that have been suppressed, may also enhance long-term disease control and survival.
Hoag Family Cancer Institute, Newport Beach, California.
Robert O
RO
Dillman
D000951:Antigens, Neoplasm / Q000276:immunology*; D019496:Cancer Vaccines / Q000008:administration & dosage*; D003713:Dendritic Cells / Q000276:immunology / Q000637:transplantation*; D018450:Disease Progression; D018572:Disease-Free Survival; D006801:Humans; D007167:Immunotherapy; D008113:Liver Neoplasms / Q000276:immunology / Q000401:mortality* / Q000556:secondary / Q000628:therapy; D008297:Male; D008545:Melanoma / Q000276:immunology / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D008875:Middle Aged; D012878:Skin Neoplasms / Q000276:immunology / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D015996:Survival Rate
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines
cancer stem cells; dendritic cells; liver metastases; melanoma; vaccine